Neill is an internationally networked pharmaceutical executive with an extensive operational, business, commercial, licensing and R&D background in a range of therapeutic areas. He holds a PhD in immunology and post-doctoral work at the National Institute for Medical Research with the MRC. He joined Wellcome plc as Head of the Immunology Department continuing with Mallinckrodt Inc. Over the last eighteen years, he has served on the Boards of listed (both the full London Stock Exchange (LSE) and the Alternative Investment Market (AIM)) and private companies in the UK and Germany as an Executive Director with P&L responsibilities, and has raised over $150 million equity capital from private and public funds.
pharmaceutical immunology